Literature DB >> 7820058

Incidence and significance of abdominal lymphadenopathy in hairy cell leukaemia.

J Mercieca1, M Puga, E Matutes, E Moskovic, S Salim, D Catovsky.   

Abstract

We have investigated the incidence and significance of abdominal lymphadenopathy in hairy cell leukemia (HCL) by routinely CT scanning 88 patients. These included 70 men and 18 women with a median age of 51 years (range 25-83). Abdominal CT scans were performed at diagnosis in 29 patients and in 59 during the course of the disease. Abdominal lymphadenopathy was documented in 25 patients (28%) overall; the incidence of abdominal lymphadenopathy was higher in relapse (56%) than at diagnosis (17%). All patients with lymphadenopathy had bone marrow disease. There is no association with age or sex but lymphadenopathy tends to be more common in patients with long-standing disease (median duration of disease 6 years v one year in those without nodes) and in patients with bulky disease, particularly in the relapse group (splenomegaly/splenectomy in 95% vs 40%). The presence of abdominal nodes is also associated with relative resistance to treatment, with more treatment failures and fewer complete responses seen in this group. Most patients with lymphadenopathy had large, immature-looking hairy cells present in both the bone marrow and lymph nodes, when these were examined. Abdominal lymphadenopathy in HCL is more common than previously recognised, particularly in relapsed patients, and is always associated with active disease. The presence of large hairy cells and the relative resistance to treatment suggest that this phenomenon represents a form of transformation of the disease. Longer follow up is required to confirm this.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7820058

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN: 1026-8022


  7 in total

Review 1.  Hairy cell leukemia.

Authors:  Ronan Swords; Francis Giles
Journal:  Med Oncol       Date:  2007       Impact factor: 3.064

Review 2.  Hairy cell leukemia.

Authors:  Claire Dearden; Monica Else
Journal:  Curr Oncol Rep       Date:  2006-09       Impact factor: 5.075

Review 3.  Hairy Cell Leukaemia.

Authors:  Matthew Cross; Claire Dearden
Journal:  Curr Oncol Rep       Date:  2020-04-16       Impact factor: 5.075

Review 4.  Update on the biology and treatment options for hairy cell leukemia.

Authors:  Preetesh Jain; Naveen Pemmaraju; Farhad Ravandi
Journal:  Curr Treat Options Oncol       Date:  2014-06

5.  VH4-34+ hairy cell leukemia, a new variant with poor prognosis despite standard therapy.

Authors:  Evgeny Arons; Tara Suntum; Maryalice Stetler-Stevenson; Robert J Kreitman
Journal:  Blood       Date:  2009-09-10       Impact factor: 22.113

6.  Synchronous Detection of Hairy Cell Leukemia and HIV-Negative Kaposi's Sarcoma of the Lymph Node: A Diagnostic Challenge and a Rare Coincidence.

Authors:  Seniz Ongoren Aydin; Ahmet Emre Eskazan; Hilal Aki; Mustafa Ozguroglu; Zafer Baslar; Teoman Soysal
Journal:  Case Rep Oncol       Date:  2011-09-03

7.  Hairy cell leukemia: a diagnosis by endoscopic ultrasound guided fine needle aspiration.

Authors:  Regina S Meara; Vishnu Reddy; Juan Pablo Arnoletti; Darshana Jhala; Shyam Varadarajulu; Nirag Jhala
Journal:  Cytojournal       Date:  2006-01-23       Impact factor: 2.091

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.